Transforming growth factor β (TGFβ)‐induced HK2 and glucosamine (GlcN)‐induced HepG2 cells were utilized to validate the pharmacological effect of renal fibrosis and insulin resistance regulated by the two formulae, respectively. This evidence concerns the gene TGFB1 and renal fibrosis.